Advertisement
Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin's lymphoma drug Rituxan

FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug

0
Truxima approved to treat adults with CD20-positive, B-cell non-Hodgkin's lymphoma
Among older patients with polycythemia vera

Recommended Therapies for Polycythemia Vera Underused

0
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients
Nearly one in five patients undergoing head and neck cancer surgery reconstruction is readmitted within 30 days of surgery

One in Five Readmitted After Head, Neck Cancer Reconstruction

0
Both sociodemographic and clinical features up the rate of readmission
Patient and family partnership in care should include treatment of patients and families with dignity and respect

Four Principles Underlie Patient and Family Partnership in Care

0
Patients, families should be treated with dignity and respect, be actively engaged in care
A major update of the United States' system for approving medical devices was announced yesterday by the Food and Drug Administration.

FDA to Update Medical Device Approvals Process

0
Revised process will ensure new medical devices meet safety and effectiveness standards
Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific genetic feature.

FDA Approves Vitrakvi for Cancers With Certain Genetic Trait

0
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
For patients with prostate cancer

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

0
Heart failure risk higher for androgen deprivation therapy users in propensity score-matched analysis
The American Lung Association and the American Thoracic Society have established a website to guide implementation of lung cancer screening

Lung Cancer Screening Implementation Guide Developed

0
Implementation guide designed to increase levels of lung cancer screening for heavy smokers
Even with the rapid rise in popularity of electronic cigarettes

Youth Smoking Decline Mirrors Rise in Vaping Popularity

0
Large rise in youth vaping, decline in past 30-day smoking prevalence accelerated around 2014
Millions of workers gained insurance coverage under the Affordable Care Act without adverse effects on labor markets

ACA Coverage Substantial, but Did Not Impact Labor Markets

0
Coverage gains did not negatively impact employment levels, hours worked, earnings